Litigation Details for VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. PAR PHARMACEUTICAL, INC. (D.N.J. 2018)
✉ Email this page to a colleague
VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. PAR PHARMACEUTICAL, INC. (D.N.J. 2018)
| Docket | ⤷ Subscribe | Date Filed | 2018-09-09 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-12-12 |
| Cause | 35:271 Patent Infringement | Assigned To | Peter G. Sheridan |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Patents | 7,214,506; 8,039,494; 8,486,978; 9,302,009; 9,566,272; 9,662,394; 9,861,698; 9,877,955 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. PAR PHARMACEUTICAL, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Subscribe .
Details for VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. PAR PHARMACEUTICAL, INC. (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-09-09 | 1 | United States Patent Nos. 7,214,506 (“the ’506 patent”), 8,039,494 (“the ’494 patent”), 8,486,978 (“…7 patent, the ’494 patent, the ’978 patent, the ’009 patent, the ’272 patent, the ’394 patent, the …’506 patent, the ’494 patent, the ’978 patent, the ’009 patent, the ’272 patent, the ’394 patent, the…’506 patent, the ’494 patent, the ’978 patent, the ’009 patent, the ’272 patent, the ’394 patent, the…’506 patent, the ’494 patent, the ’978 patent, the ’009 patent, the ’272 patent, the ’394 patent, the | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
